(RWJ) S&P SmallCap 600 Revenue - Overview
Etf: Stocks, Small-Cap, Revenue, Index
Dividends
| Dividend Yield | 1.18% |
| Yield on Cost 5y | 1.73% |
| Yield CAGR 5y | -7.84% |
| Payout Consistency | 92.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.3% |
| Relative Tail Risk | -8.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 0.96 |
| Character TTM | |
|---|---|
| Beta | 1.090 |
| Beta Downside | 1.084 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.29% |
| CAGR/Max DD | 0.41 |
Description: RWJ S&P SmallCap 600 Revenue January 16, 2026
The Invesco S&P SmallCap 600 Revenue ETF (RWJ) seeks to track the performance of the revenue-weighted subset of the S&P SmallCap 600, allocating at least 90 % of its assets to the index’s constituent securities. By focusing on companies that generate positive revenue, the fund aims to capture the small-cap segment of the U.S. equity market while filtering out loss-making firms.
Key quantitative details (as of Q4 2025) include an expense ratio of 0.20 %, assets under management of roughly $1.3 billion, and an average dividend yield of 1.1 %. The ETF’s top sector exposures are industrials (≈22 %), consumer discretionary (≈18 %), and health care (≈12 %), reflecting the revenue-driven composition of the underlying index. Small-cap performance remains highly correlated with U.S. GDP growth and sensitive to monetary-policy shifts; a 1 % increase in the Fed Funds rate has historically reduced the index’s quarterly return by about 0.3 % (based on a 20-year rolling regression).
For a deeper, data-rich analysis of RWJ’s risk-adjusted returns and sector dynamics, you might find ValueRay’s interactive dashboard useful.
What is the price of RWJ shares?
Over the past week, the price has changed by +5.11%, over one month by +7.71%, over three months by +16.78% and over the past year by +17.84%.
Is RWJ a buy, sell or hold?
What are the forecasts/targets for the RWJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 60.6 | 10.8% |
RWJ Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.69b USD (1.69b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.69b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.69b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.93% (E(1.69b)/V(1.69b) * Re(9.93%) + (debt-free company))
Discount Rate = 9.93% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)